This is pretty disgusting. The ebola patient Thomas Eric Duncan died today and ebola traders rejoice by bidding up shares of Tekmira Pharmaceuticals (TKMR) .
The sharp spike higher in Tekmira trading come right after the Texas hospital treating Duncan announced his death.
Tekmira is one of a handful of companies with experimental ebola therapies that have been used on patients stricken with the deadly virus during this recent outbreak. Traders have turned speculating in ebola stocks into a blood sport of sorts. Tekmira shares shot up because a rival drug from Chimerix (CMRX) - Get Chimerix, Inc. Report was used to treat Duncan.
When Duncan's death was announced, Chimerx shares did this:
Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback;
to send him an email.